Article Details
Retrieved on: 2018-01-11 03:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Decibel Therapeutics Inc. has raised almost $57 million from investors led by <b>Third Rock Ventures</b>, to identify specific genetic targets for patients suffering from a variety of hearing disorders; Swiss biopharma giant Novartis AG, among other companies, are investigating hearing loss drugs that use a ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here